U.S. Stem Cell Market Cap

U.S. Stem Cell has a market cap or net worth of $66.15 thousand as of March 6, 2026. Its market cap has decreased by -97.42% in one year.

Market Cap

66.15K

Enterprise Value

n/a

Revenue

82.05K

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since February 19, 2008, U.S. Stem Cell's market cap has decreased from 66.74M to 66.15K, a decrease of -99.90%. That is a compound annual growth rate of -31.86%.

Market Cap History

Date	Market Cap	% Change
Feb 26, 2026	66.15K	9,892.60%
Dec 31, 2025	662.00	-99.00%
Dec 31, 2024	66.15K	9,892.60%
Dec 26, 2023	662.00	-99.98%
Dec 30, 2022	3.05M	0.79%
Dec 31, 2021	3.02M	-43.15%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Vincerx Pharma	66.74K
Panbela Therapeutics	63.36K
Affymax	74.49K
LadRx	54.46K
Nascent Biotech	51.85K
Itoco	85.64K
PaxMedica	50.51K
Sigyn Therapeutics	94.16K

Market Cap Rankings